PARTNERSHIP OPPORTUNITIES
Want to Become the Go-To Provider for Drug Developers Leading the Covalency Renaissance?
The 2nd Covalent Drug Discovery & Development Summit served as the central hub to showcase expertise and benchmark brands as a key solutions provider and thought-leader within the small molecules space, through our bespoke commercial packages.
Capitalizing on the breakthroughs of the covalent KRAS G12C inhibitors, the momentum to deploy covalency as a primary drug discovery effort continues to grow, drawing in new and distinguished biopharma.
As they gear up to develop first-in-class covalent drugs for previously hard-to-drug targets, they need support with:
FULL EVENT GUIDE
Assay Development
Covalent Libraries & Screening
Computational Platforms
Chemoproteomics
Biophysics Characterization
Pre-Clinical & Clinical Services
Interested in Partnering in 2025?
I’m here to help and happy to set up a call so we can discuss your commercial objectives within the covalency space to establish whether partnering with this meeting aligns with your strategy.
If you offer relevant services and would like to showcase your solutions within this booming covalency space, contact us to discuss a bespoke commercial package to promote your company at next years 3rd Covalent Drug Discovery & Development Summit.
For more information, email sponsor@hansonwade.com or download the full event guide here.
Who Attended?
